Utilizing distinct CAR and TCR signaling to generate enhanced cellular immunotherapy

Utilizing distinct CAR and TCR signaling to generate enhanced cellular immunotherapy

10.4049/jimmunol.208.Supp.122.02

Saved in:

Bibliographic Details
Main Authors:	Gascoigne, Nicholas RJ, Wu, Ling, Brzostek, Joanna, Wei, Qianru, Vale, Previtha Dawn Sakthi, Koh, Clara KT, Chua, Yen Long, Yap, Jiawei, Tan, Triscilla YY, Lai, Junyun, MacAry, Paul A
Other Authors:	DEPT OF MICROBIOLOGY & IMMUNOLOGY
Format:	Article
Published:	AMER ASSOC IMMUNOLOGISTS 2023
Subjects:	Science & Technology Life Sciences & Biomedicine Immunology
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/239575
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Targeting car to the peptide?mhc complex reveals distinct signaling compared to that of tcr in a jurkat t cell model
by: Wu, Ling, et al.
Published: (2022)

CD28-CAR-T cell activation through FYN kinase signaling rather than LCK enhances therapeutic performance
by: Wu, Ling, et al.
Published: (2023)

Binding of TCR multimers and a TCR-like antibody with distinct fine-specificities is dependent on the surface density of HLA complexes
by: Low, Jianrong L., et al.
Published: (2013)

Binding of TCR Multimers and a TCR-Like Antibody with Distinct Fine-Specificities Is Dependent on the Surface Density of HLA Complexes
by: Low J.L., et al.
Published: (2018)

Expansion of an Unusual Virtual Memory CD8+ Subpopulation Bearing V?3.2 TCR in Themis-Deficient Mice
by: Prasad, Mukul, et al.
Published: (2022)

Nonstimulatory peptide-MHC enhances human T-cell antigen-specific responses by amplifying proximal TCR signaling
by: Zhao X., et al.
Published: (2019)

THEMIS: A critical TCR signal regulator for ligand discrimination
by: Gascoigne N.R.J, et al.
Published: (2016)

APPLICATIONS OF AN ANTI-EPSTEIN-BARR VIRUS LMP2A TCR-LIKE MONOCLONAL ANTIBODY: INSIGHTS TO MHC CLASS-I ANTIGEN PRESENTATION AND TARGETING OF EBV-ASSOCIATED TUMORS
by: LAI JUNYUN
Published: (2016)

Single Molecule Force Spectroscopy Reveals Distinctions in Key Biophysical Parameters of alpha beta T-Cell Receptors Compared with Chimeric Antigen Receptors Directed at the Same Ligand
by: Banik, Debasis, et al.
Published: (2023)

ROLE OF CD137 SIGNALING IN IMMUNE DEVIATION OF HODGKIN LYMPHOMA AND ITS UTILISATION IN DEVELOPMENT OF IMMUNOTHERAPY
by: SAKTHI RAJENDRAN
Published: (2017)

Allelic Exclusion of TCR α-Chains upon Severe Restriction of Vα Repertoire
by: Rybakin V., et al.
Published: (2018)

DIFFERENTIAL EFFECTS OF IMMUNOSUPPRESSANTS ON THE FUNCTION OF ENGINEERED TCR-T CELLS
by: MORTEZA HAFEZI
Published: (2019)

Trend corruption report (TCR) triwulan - III 2010
by: , Pusat Kajian Anti Korupsi Fak. Hukum UGM
Published: (2010)

Lck bound to coreceptor is less active than free Lck
by: Wei, Qianru, et al.
Published: (2023)

Themis integrates signalling from self pMHC and cytokines in mature CD8+T cells
by: Gascoigne, Nicholas RJ, et al.
Published: (2019)

Cooperative interaction of Nck and Lck orchestrates optimal TCR signaling
by: Frederike A. Hartl, et al.
Published: (2022)

Intraperitoneal immunotherapy with T cells stably and transiently expressing anti-EpCAM CAR in xenograft models of peritoneal carcinomatosis
by: Ang W.X., et al.
Published: (2020)

Defining the expression hierarchy of latent T-cell epitopes in Epstein-Barr virus infection with TCR-like antibodies
by: Sim A.C.N., et al.
Published: (2020)

TCR-like antibodies mediate complement and antibody-dependent cellular cytotoxicity against Epstein-Barr virus-transformed B lymphoblastoid cells expressing different HLA-A?02 microvariants
by: Lai J., et al.
Published: (2020)

IDENTIFYING TCR BLOCKING HLA SPECIFIC ANTIBODIES AS POTENTIAL THERAPEUTICS IN ACHIEVING TRANSPLANT TOLERANCE
by: MARYAM HAMIDINIA
Published: (2021)

Micropatterning of TCR and LFA-1 ligands reveals complementary effects on cytoskeleton mechanics in T cells
by: Tabdanov, E, et al.
Published: (2020)

Expansion of donor-unrestricted MAIT cells with enhanced cytolytic function suitable for TCR redirection
by: Parrot, Tiphaine, et al.
Published: (2022)

The role of immunotherapy in the treatment of advanced cervical cancer: Current status and future perspectives
by: Walsh, RJ, et al.
Published: (2021)

Non-canonicaly recruited TCRαβCD8αα IELs recognize microbial antigens
by: Wojciech, L., et al.
Published: (2021)

STRATEGIES TO INCREASE THE EFFICACY OF T-CELL RECEPTOR (TCR) T CELL THERAPY AGAINST HBV-RELATED HCC
by: LIN MEIYIN
Published: (2023)

Immunosuppressive Drug Resistant Armored TCR T cells for immune-therapy of HCC in liver transplant patients
by: MORTEZA HAFEZI, et al.
Published: (2021)

A defect-engineered nanozyme for targeted NIR-II photothermal immunotherapy of cancer
by: Jana, Deblin, et al.
Published: (2023)

Circulating Salivary miRNA hsa-miR-221 as Clinically Validated Diagnostic Marker for Hand, Foot, and Mouth Disease in Pediatric Patients
by: Min, Nyo, et al.
Published: (2020)

Themis-associated phosphatase activity controls signaling in T cell development
by: Mehta, Monika, et al.
Published: (2023)

Immunotherapy of bladder cancer
by: WU QINGHUI
Published: (2010)

Immunotherapy of human cancers
by: Hui, K.M., et al.
Published: (2014)

Immunotherapy for diabetic amyotrophy.
by: Chan, Y.C., et al.
Published: (2011)

Immunotherapy for diabetic amyotrophy.
by: Chan, Y.C., et al.
Published: (2016)

Immunotherapy in autoimmune diseases
by: Fong, K.Y.
Published: (2014)

Immunotherapy for diabetic amyotrophy
by: Chan, Y.-C., et al.
Published: (2016)

Immunotherapy and Biomarkers in Sarcoma
by: Thanate Dajsakdipon, et al.
Published: (2022)

Neonatal septicemia and immunotherapy
by: P. Siripoonya
Published: (2018)

Immunotherapy and Biomarkers in Sarcoma
by: Dajsakdipon T.
Published: (2023)

Immunotherapy in Multiple Myeloma
by: Soekojo, Cinnie Yentia, et al.
Published: (2022)

THE DEVELOPMENT, CHARACTERIZATION AND APPLICATION OF TCR-LIKE MONOCLONAL ANTIBODIES WITH SPECIFICITY FOR EPSTEIN-BARR VIRUS LATENT EPITOPES
by: SIM CHONG NYI ADRIAN
Published: (2012)